Fischer Krisztina, McDannold Nathan J, Tempany Clare M, Jolesz Ferenc A, Fennessy Fiona M
Department of Radiology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA ; Renal Division, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA ; Biomedical Engineering Division, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
Department of Radiology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
Int J Womens Health. 2015 Nov 13;7:901-12. doi: 10.2147/IJWH.S55564. eCollection 2015.
Minimally invasive treatment options are an important part of the uterine fibroid-treatment arsenal, especially among younger patients and in those who plan future pregnancies. This article provides an overview of the currently available minimally invasive therapy options, with a special emphasis on a completely noninvasive option: magnetic resonance-guided focused ultrasound (MRgFUS). In this review, we describe the background of MRgFUS, the patient-selection criteria for MRgFUS, and how the procedure is performed. We summarize the published clinical trial results, and review the literature on pregnancy post-MRgFUS and on the cost-effectiveness of MRgFUS.
微创治疗方案是子宫肌瘤治疗手段的重要组成部分,尤其在年轻患者以及计划未来怀孕的患者中。本文概述了目前可用的微创治疗方案,特别强调一种完全无创的方案:磁共振引导聚焦超声(MRgFUS)。在本综述中,我们描述了MRgFUS的背景、MRgFUS的患者选择标准以及该手术的实施方式。我们总结了已发表的临床试验结果,并回顾了关于MRgFUS术后妊娠以及MRgFUS成本效益的文献。